Rivaroxaban D4 structure
|
Common Name | Rivaroxaban D4 | ||
|---|---|---|---|---|
| CAS Number | 1132681-38-9 | Molecular Weight | 439.90600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H14D4ClN3O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Rivaroxaban D4Rivaroxaban D4 (BAY 59-7939 D4) is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM)[1][2]. |
| Name | 5-chloro-N-[[(5S)-2-oxo-3-[2,3,5,6-tetradeuterio-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | Rivaroxaban D4 (BAY 59-7939 D4) is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM)[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.7 nM (Factor Xa); Ki: 0.4 nM (Factor Xa)[1][2] |
| References |
| Molecular Formula | C19H14D4ClN3O5S |
|---|---|
| Molecular Weight | 439.90600 |
| Exact Mass | 439.09100 |
| PSA | 116.42000 |
| LogP | 3.04080 |
| InChIKey | KGFYHTZWPPHNLQ-UJCPGTITSA-N |
| SMILES | O=C(NCC1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1 |
| Storage condition | 2-8°C |
| BAY 59-7939-d4 |
| 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl-d4]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide |
| Rivaroxaban-d4 |
| [2H4]-Rivaroxaban |